A detailed history of Capital Performance Advisors LLP transactions in Mckesson Corp stock. As of the latest transaction made, Capital Performance Advisors LLP holds 544 shares of MCK stock, worth $428,285. This represents 0.07% of its overall portfolio holdings.

Number of Shares
544
Previous 542 0.37%
Holding current value
$428,285
Previous $397,000 5.79%
% of portfolio
0.07%
Previous 0.08%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 22, 2025

BUY
$659.01 - $772.54 $1,318 - $1,545
2 Added 0.37%
544 $420,000
Q2 2025

Aug 04, 2025

BUY
$652.83 - $732.78 $27,418 - $30,776
42 Added 8.4%
542 $397,000
Q1 2025

May 09, 2025

BUY
$566.21 - $672.99 $77,004 - $91,526
136 Added 37.36%
500 $336,000
Q4 2024

Jan 31, 2025

BUY
$482.27 - $628.5 $161,560 - $210,547
335 Added 1155.17%
364 $207,000
Q3 2024

Nov 01, 2024

BUY
$479.06 - $630.38 $13,892 - $18,281
29 New
29 $14,000

Others Institutions Holding MCK

About MCKESSON CORP


  • Ticker MCK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 143,730,000
  • Market Cap $113B
  • Description
  • McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...
More about MCK
Track This Portfolio

Track Capital Performance Advisors LLP Portfolio

Follow Capital Performance Advisors LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Performance Advisors LLP, based on Form 13F filings with the SEC.

News

Stay updated on Capital Performance Advisors LLP with notifications on news.